Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief
NCT ID: NCT05877521
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE2
76 participants
INTERVENTIONAL
2023-05-16
2027-05-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota
NCT07291011
Mindfulness-Based Stress Reduction to Improve Well-being in Black Adult Cancer Survivors, Community Faith-based Mindfulness Ministry
NCT06767475
Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers
NCT04870788
Mindfulness Based Stress Reduction: Supportive Treatment for Adult Patients With Cancer and Their Partners
NCT01074528
Mindfulness-Based Art Therapy for Cancer Patients
NCT00034970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wait List Control (WLC) Usual Care Procedure
Participants in the WLC group continue to receive their standard medical care and pain management as prescribed by their physicians or other health care providers.
Standard of Care for Pain Management
Participants in the WLC group continue to receive their standard medical care and pain management as prescribed by their physicians or other health care providers.
16-hour MORE treatments
Patients in the 16-hour MORE format will receive one 2hrs treatment a week for 8 consecutive weeks (as per study schema: from week 1 to week 8).
MORE treatments
MORE participants will also be asked to engage in 15 minutes/day of skill practice at home, and complete daily diaries of mindfulness practice time
8-hour MORE treatments
Patients in the 8-hour MORE format will receive one 2hrs treatment a week for 4 consecutive weeks (as per study schema: from week 1 to week 4).
MORE treatments
MORE participants will also be asked to engage in 15 minutes/day of skill practice at home, and complete daily diaries of mindfulness practice time
2-hour MORE treatments
Patients in the 2-hour MORE format will receive one 2hrs treatment (as per study schema: in week 1).
MORE treatments
MORE participants will also be asked to engage in 15 minutes/day of skill practice at home, and complete daily diaries of mindfulness practice time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MORE treatments
MORE participants will also be asked to engage in 15 minutes/day of skill practice at home, and complete daily diaries of mindfulness practice time
Standard of Care for Pain Management
Participants in the WLC group continue to receive their standard medical care and pain management as prescribed by their physicians or other health care providers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years or older
* A history of cancer with no restrictions placed on type of cancer
* Determined to be either no-evidence of disease or stable oncological disease by referring or study physicians/advanced practice providers
* Having a pain (musculoskeletal, generalized, or neuropathic) rating of 4 or greater in worst pain on a 0-10 numerical rating scale in the preceding week
* Having had pain for at least 3 months and at least 15 days with pain in the preceding 30 days
* Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: MORE or WLC
* Ability to attend video-call session and a quiet/private location
Exclusion Criteria
* Plan to initiate palliative radiation or interventional pain procedure within the next 12 weeks
* Cognitive impairment preventing completing PRO independently or participate in virtual MORE as evaluated by study clinicians
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jun Mao, MD, MSCE
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.